Diet-induced metabolic change induces estrogen-independent allometric mammary growth
- 17 September 2012
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 109 (40) , 16294-16299
Abstract
Lifetime breast cancer risk reflects an unresolved combination of early life factors including diet, body mass index, metabolic syndrome, obesity, and age at first menses. In parallel, the onset of allometric growth by the mammary glands around puberty is widely held to be estrogen (E)-dependent. Here we report that several physiological changes associated with metabolic syndrome in response to a diet supplemented with the trans-10, cis-12 isomer of conjugated linoleic acid lead to ovary-independent allometric growth of the mammary ducts. The E-independence of this diet-induced growth was highlighted by the fact that it occurred both in male mice and with pharmacological inhibition of either E receptor function or E biosynthesis. Reversal of the metabolic phenotype with the peroxisome proliferator-activated receptor-γ agonist rosiglitazone abrogated diet-induced mammary growth. A role for hyperinsulinemia and increased insulin-like growth factor-I receptor (IGF-IR) expression during mammary growth induced by the trans-10, cis-12 isomer of conjugated linoleic acid was confirmed by its reversal upon pharmacological inhibition of IGF-IR function. Diet-stimulated ductal growth also increased mammary tumorigenesis in ovariectomized polyomavirus middle T-antigen mice. Our data demonstrate that diet-induced metabolic dysregulation, independently of ovarian function, stimulates allometric growth within the mammary glands via an IGF-IR-dependent mechanism.Keywords
This publication has 52 references indexed in Scilit:
- A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast CancerCancer Research, 2011
- Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?Current Breast Cancer Reports, 2011
- t10,c12-CLA decreases adiposity in peripubertal mice without dose-related detrimental effects on mammary development, inflammation status, and metabolismAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010
- Diverse and Active Roles for Adipocytes During Mammary Gland Growth and FunctionJournal of Mammary Gland Biology and Neoplasia, 2010
- Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapyProceedings of the National Academy of Sciences, 2010
- Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 DiabetesCancer Research, 2010
- Insulin-Like Growth Factor Type 1 Receptor and Insulin Receptor Isoform Expression and Signaling in Mammary Epithelial CellsEndocrinology, 2009
- Weight, Dietary Behavior, and Physical Activity in Childhood and Adolescence: Implications for Adult Cancer RiskObesity Facts, 2009
- Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal WomenJNCI: Journal of the National Cancer Institute, 2008
- The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epitheliumCarcinogenesis, 2007